Growth of Sepsis Diagnostics Market: Therapeutics Development Details, Key Regions Analysis with Study of Top Players and Forecast till 2026

The global market discussion on sepsis diagnostics industry can be found in the latest study by Fact.MR, which has been freshly added to its massive collection of research database. The report is titled “Sepsis Diagnostics Market Forecast, Trend Analysis & Competition Tracking: Global Review 2017 to 2026”, which works to enlighten the readers about the major factors prompting the growth of the concerned market. Apart from that, the research majorly focuses on sepsis diagnostics market’s competitive outlook by profiling major players functioning across the globe. As the report moves ahead, information regarding the prominent trends as well as opportunities in the key geographical segments have also been elaborated, thus enabling companies to be able to make region-specific strategies for gaining competitive lead. Some of the prime regions emphasized in the study include key regions.

Get A Free Sample Copy of Report@ https://www.factmr.com/connectus/sample?flag=S&rep_id=391

According to a study by Fact.MR, the global sepsis diagnostics market is expected to witness strong growth, registering 7.7% CAGR during the forecast period 2017-2026. The global sepsis diagnostics market is also projected to generate US$ 707.3 million revenue by the end of 2026. Owing to the increase in scope and applications, significant growth is expected in the market. Moreover, early detection has been shown to be crucial for the better outcome of patients suffering from sepsis. Following are the insights on how the global sepsis diagnostics market will perform in the coming years.

Assays & Reagents to Emerge as the Top-Selling Product

Among various products in sepsis diagnostics market, assays & reagents are likely to emerge as the top-selling products. Assays & reagents are projected to surpass US$ 300 million revenue by end of the forecast period. Reagents and assays kits are showing lucrative growth due to the introduction of technically advanced tests by key players. Moreover, assays and reagents facilitate early diagnosis of sepsis.

Conventional Diagnostics to be the Most-Preferred diagnostic Method

Compared to the automated diagnostics, conventional diagnostics is likely to emerge as the most-preferred sepsis diagnosis method. Towards 2026 end, conventional diagnostics is projected to generate more than US$ 400 million revenue. Conventional methods for diagnosis of sepsis is still the most-preferred one due to the low cost and it also leads to the timely changes to appropriate therapy.

Gram-positive Bacterial Sepsis to Hold the Largest Share on Basis of Pathogens Causing Septicemia

Gram-positive bacterial sepsis segment is likely to account for the maximum share in terms of revenue in the global market for sepsis diagnostics. Gram-positive bacterial sepsis are projected to reach close to US$ 300 million revenue by 2026 end. Although bacteria causes sepsis on a large scale, the increase in sepsis is due to the gram-positive sepsis. Various studies carried on sepsis are showing that gram-positive bacteria accounts for maximum septic shock and severe sepsis cases. Moreover, the mortality rate due to gram-positive infection is high as compared to the gram-negative infection. Hence, therapeutic protocols are being undertaken to manage both gram-positive and gram-negative sepsis.

Microbiology Technology to Witness Attractive Growth between 2017 and 2026

Compared to the various technologies, microbiology is likely to show attractive growth between 2017 and 2026. Microbiology technology is projected to reach nearly US$ 300 million revenue by 2026 end. It helps in identifying microorganisms for sepsis diagnosis and quantitative detection through culture media tests. Meanwhile, molecular diagnostics is also gaining traction in the market. Factors contributing to the growth of molecular diagnostics are accurate results and low turnaround time.

Competition Tracking

The report also profiles companies that are expected to remain active in the expansion of global sepsis diagnostics market through 2026, which include Abionic SA, Biomérieux SA, Siemens Healthineers, Thermo Fisher Scientific Inc., Quidel Corporation, Becton, Dickinson and Company, Luminex Corporation, Abbott Laboratories, Inc., Qiagen NV, T2 Biosystems, Inc., Roche Holdings AG (Roche Diagnostics Limited), and Danaher Corporation (Beckman Coulter, Inc.).

Browse Full Report with TOC@ https://www.factmr.com/report/391/sepsis-diagnostics-market

Table of Contents:

Global Economic Outlook
Global Sepsis Diagnostics Market – Executive Summary
Global Sepsis Diagnostics Market Overview
3.1. Introduction
3.1.1. Global Sepsis Diagnostics Market Taxonomy
3.1.2. Global Sepsis Diagnostics Market Definition
3.2. Global Sepsis Diagnostics Market Size (US$ Mn) and Forecast, 2012-2026
3.2.1. Global Sepsis Diagnostics Market Y-o-Y Growth
3.3. Global Sepsis Diagnostics Market Dynamics
3.4. Supply Chain
3.5. Cost Structure
3.6. New Technologies
3.7. Sepsis types and mortality rates
3.8. Application of Sepsis Biomarkers
3.9. Early antimicrobial therapy in Septic Shock treatment
3.10. Commercially available systems and assays used for Sepsis diagnostics
3.11. Sepsis Epidemiology
3.12. Death rate of Sepsis as compared to other diseases
3.13. Surviving Sepsis Campaign
3.13.1. Surviving Sepsis Campaign Guideline Process
3.14. PESTL Analysis
3.15. Product Lifecycle
3.16. Patent Analysis
3.17. Service Provider List
3.18. Key Participants Market Presence (Intensity Map) By Region
Continued…………

Browse Full Report with TOC@ https://www.factmr.com/connectus/sample?flag=D&rep_id=391

About Fact.MR
Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that’s why we publish multi-industry global, regional, and country-specific research reports.

Contact Us
Fact.MR
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Email: sales@factmr.com
Web: https://www.factmr.com/

This release was published on openPR.